Ken Courtenay

  • Citations Per Year
Learn More
BACKGROUND People with intellectual disabilities (ID) have many comorbidities but experience inequities in access to health care. National Health Service England uses an opt-in incentive scheme to encourage annual health checks of patients with ID in primary care. We investigated whether the first 3 years of the programme had improved health care of people(More)
BOOK Scientific Committee: Seija Aaltonen (Finland), Marco O. Bertelli (Italy), Annette Borkfelt (Denmark), Roger Banks (United Kingdom), Raymond Ceccotto (Luxembourg), Ken Courtenay (United Kingdom), Johan De Groef (Belgium), Anton Došen (The Netherlands), Knut Hoffmann (Germany), Sheila Hollins (United Kingdom), Milivoj Kramaric (Croatia), Stefano Lassi(More)
People with intellectual disabilities (ID) present with behaviours that challenge community services. Community models of care as alternatives to hospital care exist but are often vary in their function. Certain strategies have been developed to manage challenging behaviour in people with ID. Data from a three-year period on a community-based service for(More)
People with Intellectual Disability (ID) have cognitive impairments that affect their level of functioning the causes of which are multiple and often unknown. Behavioural difficulties are common among people with ID. Attention Deficit Hyperactivity Disorder (ADHD) is recognised more among people with Intellectual Disability and could be a cause of problem(More)
Given medical and social advances, the life expectancy of individuals with intellectual disability (ID) has increased dramatically, leading to a generation of older individuals with such disabilities. This review focuses on the pharmacological treatment of behavioral and psychiatric symptoms and disorders in older adults with ID. Older adults with ID often(More)
Background: People with Down syndrome (DS) are an ultra-high risk population for Alzheimer’s disease (AD). Understanding the factors associated with age of onset and survival in this population could highlight factors associated with modulation of the amyloid cascade. Objective: This study aimed to establish the typical age at diagnosis and survival(More)